Hieronder vindt u verwijzingen naar methodologische of beschouwende artikelen op het gebied van kosteneffectiviteit van preventie.

Reviews of surveys

Reviews of surveys over economische evaluaties

Economic evaluations of eHealth technologies: A systematic review (Sanyal et al., 2018)

The cost-effectiveness of public health interventions examined by NICE from 2011 to 2016 (Owen et al., 2017)

Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss (Hernaes et al., 2017)

Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models: Stop Developing, Start Evaluating (van Giessen et al., 2017)

Evidence synthesis to inform model-based cost-effectiveness evaluations of diagnostic tests: a methodological review of health technology assessments (Shinkins et al., 2017)

Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators (Roseboom et al., 2017)

A literature-based economic evaluation of healthcare preventable adverse events in Europe (Agbabiaka et al., 2016)

Cost-effectiveness and sustainability of breast cancer screening and new anticancer drugs (Mustacchi & Generali, 2017)

How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3) (Van Mastrigt et al., 2016)

How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3) (Thielen et al., 2016)

How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (Part 3/3) (Wijnen et al., 2016)

A Systematic Review of Health Economic Evaluation Studies Using the Patient's Perspective (Bilvick Tai et al., 2016)

Lack of Cost-Effectiveness Analyses to Address Healthy People 2020 Priority Areas (Neumann et al., 2016)

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial (Verguet et al., 2016)

Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature (Pitt et al., 2016)

Systematic overview of cost-effectiveness thresholds in ten countries across four continents (Schwarzer et al., 2015)

Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making? (Pan et al., 2015)

A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers (Oosterhoff et al., 2015)

Conducting systematic reviews of economic evaluations (Gomersall et al., 2015)

The changing face of the cost-utility literature, 1990-2012 (Neumann et al., 2015)

A decade of investment in infection prevention: A cost-effectiveness analysis  (Dick et al., 2015)

Estimating QALY Gaines in Applied Studies: A Review of Cost-Utility Analyses Published in 2010 (Wisloff et al., 2014)

Generalizability of cost-utility analyses across countries and settings  (Ginsberg, 2013)

The role of health economic analyses in vaccine decision making  (Black, 2013)

Research Priorities for Economic Analyses of Prevention: Current Issues and Future Directions  (Crowley et al., 2013)

Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines (De la Hoz-Restrepo et al., 2013)

Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012 (Cortes et al., 2013)

Timely and complete publication of economic evaluations alongside randomized controlled trials  (Thorn et al., 2013)

Public health and prevention in Europe: is it cost-effective? (Simoens, 2011)

Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis  (Catala-Lopez et al., 2012)

Making the economic case for prevention - a view from Wales  (Hale et al., 2012)

Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis (Salomon et al., 2012)

Cost-Effectiveness of Antiretroviral Therapy for Prevention (Kahn et al., 2011)

Cost-effectiveness research on preventive interventions: a survey of the publications in 2008 (van Gils et al., 2010).

Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters? (Catala-Lopez et al., 2011)

Does prevention really pay? (Daly, 2011)

Are economic evaluations an important tool in vaccine policy decisions? (Jacobs, 2011)


Methodologie van economische evaluaties

Simple but not simpler: a systematic review of Markov models for economic evaluation of cervical cancer screening (Viscondi et al., 2018)

The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds? (Sandmann et al., 2018)

Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic Review (Silva-Illanes & Espinoza, 2018)

Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis (Iraqorri & Spackman, 2018)

Systematic assessment of decision analytic models for the cost-effectiveness of bariatric surgery for morbid obesity (Alsumali et al., 2018)

A qualitative investigation of the health economic impacts of bariatric surgery for obesity and implications for improved practice in health economics (Campbell et al., 2018)

The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study (Leal et al., 2018)

Reconciling ethical and economic conceptions of value in health policy using the capabilities approach: A qualitative investigation of Non-Invasive Prenatal Testing (Kibel & Vanstone, 2017)

A method for the inclusion of physical activity-related health benefits in cost-benefit analysis of built environment initiatives (Zapata-Diomedi et al., 2017)

Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used (Nymark et al., 2017)

Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine (Padula et al., 2017)

WHO guide on the economic evaluation of influenza vaccination (Newall et al.,. 2017)

A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models (Brazier et al., 2017)

Challenges and recommendations for the health-economic evaluation of primary prevention programmes for dementia (Handels & Wimo, 2017)

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework (Carvalho et al., 2017)

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs (Bilinski et al., 2017)

The search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with substance use disorder and delinquent behavior: a systematic literature review (Schawo et al., 2017)

Predicting carer health effects for use in economic evaluation (Al-Janabi et al., 2017)

Inclusion of equity in economic analyses of public health policies: systematic review and future directions (Lal et al., 2017)

Dynamic transmission models for economic analysis applied to health care-associated infections: A review of the literature (Nelson et al., 2017)

How to design the cost-effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework (Johanessen et al., 2017)

Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation (Coyle et al., 2017)

A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies (Ortendahl et al., 2017)

Modelling and optimal control of pneumonia disease with cost-effective strategies (Tilahun et al., 2017)

Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV (Custer et al., 2017)

Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies (Makady et al., 2017)

The influence of time horizon on results of cost-effectiveness analyses (Kim et al., 2017)

Accounting for Cured Patients in Cost-Effectiveness Analysis (Othus et al., 2017)

Economics in "Global Health 2035": a sensitivity analysis of the value of a life year estimates (Chang et al., 2017)

Why Early Prevention of Childhood Obesity Is More Than a Medical Concern: A Health Economic Approach (Sonntag, 2017)

Using Cost-Effectiveness Analysis to Address Health Equity Concerns (Cookson et al., 2017)

Mix and match. A simulation study on the impact of mixed-treatment comparison methods on health-economic outcomes (Vemer et al., 2017)

The insights of health and welfare professionals on hurdles that impede economic evaluations of welfare interventions (Schepers et al., 2017)

Beyond cost-effectiveness: Using systems analysis for infectious disease preparedness (Phelps et al., 2017)

Risk of bias in model-based economic evaluations: the ECOBIAS checklist (Adarkwah et al., 2016)

Valuing Meta-Health Effects for Use in Economic Evaluations to Inform Reimbursement Decisions: A Review of the Evidence (De Abreu Lourenco et al., 2016)

Maximizing Health or Sufficient Capability in Economic Evaluation? A Methodological Experiment of Treatment for Drug Addiction (Goranitis et al., 2016)

Emergent Challenges in Determining Costs for Economic Evaluations (Jacobs & Barnett, 2016)

Economic Evaluation of Obesity Prevention in Early Childhood: Methods, Limitations and Recommendations (Döring et al., 2016)

Economic evaluation of integrated new technologies for health and social care: Suggestions for policy makers, users and evaluators (Wildman et al., 2016)

Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations (Ekwunife et al., 2016)

A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines (Thiboonboon et al., 2016)

Systematic review and overview of health economic evaluation models in obesity prevention and therapy (Schwander et al., 2016)

A Framework for Developing the Structure of Public Health Economic Models (Squires et al., 2016)

Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer (de Boer et al., 2016)

Strengthening Cost-Effectiveness Analysis for Public Health Policy (Russell & Sinha, 2016)

Cost Effectiveness of HPV Vaccination: A Systematic Review of Modelling Approaches (Pink et al., 2016)

A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems (Hoang et al., 2016)

Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges (Dirmesropian et al., 2016)

Economic Evaluation of Mental Health Interventions: A Guide to Costing Approaches (Shearer et al., 2016)

Economic Evaluation of Childhood Obesity Interventions: Reflections and Suggestions (Frew, 2016)

NETIMIS: Dynamic Simulation of Health Economics Outcomes Using Big Data (Johnson et al., 2016)

Modeling and Cost-Effectiveness in HIV Prevention (Jacobsen & Walensky, 2016)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? (Jit & Hutubessy, 2016)

A systematic literature review of the key challenges for developing the structure of public health economic models (Squires et al., 2016)

Beware of Kinked Frontiers: A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening (O'Mahony et al., 2015)

Quality assessment of economic evaluations of health promotion programs for children and adolescents-a systematic review using the example of physical activity (Korber, 2015)

Methods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic Review (Sutton et al., 2015)

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community (Ultsch et al., 2016)

How to Measure Costs and Benefits of eHealth Interventions: An Overview of Methods and Frameworks (Bergmo, 2015)

A qualitative study on the views of experts regarding the incorporation of non-health outcomes into the economic evaluations of public health interventions (van Mastrigt et al., 2015)

The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling (van Voorn et al., 2015)

Incorporating Psychological Predictors of Treatment Response into Health Economic Simulation Models: A Case Study in Type 1 Diabetes (Kruger et al., 2015)

A Framework for Including Family Health Spillovers in Economic Evaluation (Al-Janabi et al., 2015)

Cost-Effective Control of Infectious Disease Outbreaks Accounting for Societal Reaction (Fast et al., 2015)

Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening (Curl et al., 2015)

Exploring Outcomes to Consider in Economic Evaluations of Health Promotion Programs: What Broader Non-Health Outcomes Matter Most? (Benning et al., 2015)

Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review (Jit & Mibei, 2015)

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice (O'Mahony et al., 2015)

Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study (van der Putten et al., 2015)

Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe (Blau et al., 2015)

Costing bias in economic evaluations (Frappier et al., 2015)

Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses (Welton et al., 2015)


Sustainability of Behavioral Interventions: Beyond Cost-Effectiveness Analysis (Brown et al., 2014)


Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis (Norheim et al., 2014)

Estimating Productivity Costs in Health Economic Evaluations: A Review of Instruments and Psychometric Evidence (Tang, 2014)

Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries (Simonella & Canfell, 2014)

Mind the gaps: what's missing from current economic evaluations of universal HPV vaccination? (Marsh et al., 2014)

Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe (Divajeva et al., 2014)


Avoiding research waste through cost-effectiveness analysis: the example of medication adherence-enhancing interventions (Gandjour, 2014)

Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination (Quinn et al., 2014)

Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease (Burgers et al., 2014)

Methodological issues for the economic evaluation of health interventions: A concise state of the art (Di Tanna & Baio, 2013)

Inter-sectoral costs and benefits of mental health prevention: towards a new classification scheme (Drost et al., 2013)

A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assited Reduction then Stop (EARS) among disadvantaged smoker (Taylor et al., 2014

Estimating QALY Gaines in Applied Studies: A Review of Cost-Utility Analyses Published in 2010 (Wisloff et al., 2014)

Perspectives on econometric modelling to inform policy: a UK qualitative case study of minimum unit pricing of alcohol  (Katikireddi et al., 2013)

How to include informal care in economic evaluations  (Hoefman et al., 2013)

Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses  (Newall et al., 2013)

TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination (Clark et al., 2013)

Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions (Getsios et al., 2013)

A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions (Postmus et al., 2013)

The use of cost-benefit analysis in road assessments: a methodological inquiry (Vecino-Ortiz & Hyder, 2013

Cost-effectiveness analyses of training: a manager's guide  (O. Malley G et al., 2013)

Understanding the Cost-Effectiveness of Influenza Vaccination in Children: Methodological Choices and Seasonal Variability (Newall et al., 2013)

A critical literature review of health economic evaluations of rotavirus vaccination  (Aballea et al., 2013

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (Husereau et al., 2013)

Endogenous cost-effectiveness analysis and health care technology adoption  (Jena & Philipson, 2012)

Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions  (Farkouh et al., 2012)

Incorporating social network effects into cost-effectiveness analysis: a methodological contribution with application to obesity prevention (Konchak & Prasad, 2012)

Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening (Langer et al., 2012)

Multicohort Models in Cost-Effectiveness Analysis: Why Aggregating Estimates over Multiple Cohorts Can Hide Useful Information (O'Mahony et al., 2012)

Applying economic evaluation to public health interventions: the case of interventions to promote physical activity (Trueman & Anokye, 2012)

Estimating cost-effectiveness in public health: a summary of modelling and valuation methods (Marsh et al., 2012)

Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus  (Bärnighausen et al., 2012)

Applying the net-benefit framework for analyzing and presenting cost-effectiveness analysis of a maternal and newborn health intervention   (Hounton & Newlands, 2012b)

Methods for Estimating Subgroup Effects in Cost-Effectiveness Analyses That Use Observational Data   (Kreif et al., 2012)

Applying the net-benefit framework for assessing cost-effectiveness of interventions towards universal health coverage  (Hounton & Newlands, 2012)

Decision analysis, economic evaluation, and newborn screening: challenges and opportunities (Prosser et al., 2012)

Valuing the economic benefits of complex interventions: when maximising health is not sufficient (Payne et al., 2012)

A critical literature review of health economic evaluations in pertussis booster vaccination (Millier et al., 2012)

Moving beyond a limited follow-up in cost-effectiveness analyses of behavioral interventions (Prenger et al., 2012)

Average cost-effectiveness ratio with censored data (Bang & Zhao, 2012)

The CHD challenge: Comparing cost-effectiveness models  (Turner et al., 2011)

The quality of three decision-analytic diabetes models: a systematic health economic assessment (Becker et al., 2011)

Characteristics and quality of pediatric cost-utility analyses (Kromm et al., 2011)

Application of Classic Utilities to Published Pediatric Cost-Utility Studies (Finnell et al., 2011)

Methodological concerns with economic evaluations of meningococcal vaccines (Kauf, 2010).

Human papillomavirus vaccine introduction in low and middle income countries: guidance on the use of cost-effectiveness models (Jit et al., 2011)

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools (Chaiyakunapruk et al., 2011)

Cost-utility analysis: current methodological issues and future perspectives (Nuijten & Dubois, 2011)

Conceptual Framework for Standard Economic Evaluation of Physical Activity Programs in Primary Prevention (Wolfenstetter, 2011)

Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination (Garrison, L. P. et al., 2011)

Patient experience - the ingredient missing from cost-effectiveness calculations (Curtis, 2011)

Power and sample size for cost-effectiveness analysis: fFN neonatal screening (Boyd et al., 2011)

Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach (Hawkins et al., 2011)

The cost-effectiveness of public health interventions (Owen et al., 2011)

Cost-effectiveness of osteoporosis screening followed by treatment: the impact of medication adherence (Hiligsmann et al., 2010)

Developing guidelines for good practice in the economic evaluation of occupational safety and health interventions (Tompa et al., 2010).

Conducting cost-effectiveness analyses of type 2 diabetes in low- and middle income countries: can locally generated observational study data overcome methodological limitations? (Baik et al., 2010)

Estimation of life-years gained and cost effectiveness based on cause-specific mortality (Kim & Thompson, 2010).

Modelling lifetime QALYs and health care costs from different drinking patterns over time: a Markov model (Barbosa et al., 2010)

Future costs in cost-effectiveness analysis: an empirical assessment (Kruse et al., 2010).

Economic evaluation and the postponement of health care costs (van Baal et al., 2010-1)

Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations (van Baal et al., 2010-2)

Onzekerheid in modelstudies

Onzekerheid in modelstudies


Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine (Wasserman et al., 2017)

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient? (Curran et al., 2016)

Mind the Gap! A Multilevel Analysis of Factors Related to Variation in Published Cost-Effectiveness Estimates within and between Countries (Boehler & Lord, 2015)

The economics of vaccination (Chen & Toxvaerd, 2014)

Changes in costs and effects after the implementation of disease management programs in the Netherlands: variability and determinants (Tsiachristas et al., 2014)

Does Age Modify the Cost-Effectiveness of Community-Based Physical Activity Interventions? (Roux et al., 2014)

Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe?: A rotavirus case study (Bruggenjurgen et al., 2014)

The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening (Chauvin et al., 2013)

Cost-effectiveness: euros per QALY is not enough (van den Berg et al., 2012)

The impact of inclusion criteria in health economic assessments  (Richter et al., 2011)

Exploring Model Uncertainty in Economic Evaluation of Health Interventions: The Example of Rotavirus Vaccination in Vietnam (Kim et al., 2010)

Calibrating models in economic evaluation: a seven-step approach (Vanni et al., 2011)

Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: results are inconclusive (Mogasale & Barendregt, 2011)

Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test. (Polyzos et al., 2011)

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools (Chaiyakunapruk et al., 2011)

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal (Hutubessy et al., 2011)

Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness (Gordon et al., 2010)

Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese people  (Galani et al., 2008)


Uitkomstmaten in economische evaluaties

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted (Neumann et al., 2016)

Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US (Hoefman et al., 2016)

Determinants of Change in the Cost-Effectiveness Threshold (Paulden et al., 2016)

Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review (Herdman et al., 2016)

A systematic review of instruments for measuring outcomes in economic evaluation within aged care (Bulamu et al., 2015)

Using health state utility values in models exploring the cost-effectiveness of health technologies (Ara & Wailoo, 2012)

Cost-effectiveness comparison of breast cancer screening and vascular event primary prevention with aspirin in Wales (Morgan, 2011)

Using threshold values for cost per quality-adjusted life-year gained in healthcare decision (Cleemput et al., 2011)

Outcome measurement in economic evaluations of public health interventions: a role for the capability approach? (Lorgelly et al., 2010)

Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. (Weatherly et al., 2009)

The Potential to Forgo Social Welfare Gains through Overrelianceon Cost Effectiveness/Cost Utility Analyses in the Evidence Base for Public Health. (Cohen & Patel, 2009)

The role of costs in comparative effectiveness research. (Garber & Sox, 2010)

Cost-utility estimates in depression: does the valuation method matter? (Jonkers et al., 2010)

Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions? (Greenberg & Neumann, 2011